Rankings
▼
Calendar
KLRS FY 2018 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena
KLRS
Kalaris Therapeutics Inc
$180M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
$0
0.0% margin
Operating Income
-$4M
-316.8% margin
Net Income
-$2M
-214.1% margin
EPS (Diluted)
$-2.88
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$25M
Total Liabilities
$4M
Stockholders' Equity
$22M
Cash & Equivalents
$25M
← Q1 2019
All Quarters